Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHARLOTTE, N.C. — More than 50% of patients who came to an academic health care center with cardiac or neurological conditions also were found to have sleep apnea or other sleep disturbances, according to a study presented at SLEEP 2022. Anecdotally, these conditions are known to appear concomitantly, according to study authors.
SAN FRANCISCO — Treatment with imatinib resulted in a sustained clinical benefit after 90 days in hospitalized patients with hypoxemic COVID-19, according to results of the CounterCOVID study.At the American Thoracic Society International Conference, Job R. Schippers, MD-PhD candidate for pulmonary medicine at Amsterdam University Medical Center, presented long-term clinical outcomes at 90
CHARLOTTE, N.C. — A history of COVID-19 nearly doubled the odds of having very short sleep, according to results from a large U.S. study presented at SLEEP 2022. “Few studies have focused on factors associated with sleep quantity and quality,” Marie-Rachelle Narcisse, PhD, lead study author and assistant professor at the University of Arkansas for Medical Sciences Northwest,
CHICAGO — In what researchers described as the first randomized controlled trial of chemotherapy in relapsed or refractory Ewing sarcoma, high-dose ifosfamide proved more effective in extending survival than topotecan and cyclophosphamide. Martin G. McCabe, MD, PhD, clinical senior lecturer in pediatric and adolescent oncology at University of Manchester in the U.K., presented the
CHICAGO — A combination of two targeted therapies significantly improved outcomes compared with standard care for children with BRAF V600 mutation-positive low-grade glioma, according to study results presented at ASCO Annual Meeting.Dabrafenib (Tafinlar, Novartis) and trametinib (Mekinist, Novartis) increased response rate, extended PFS and improved clinical benefit rate compared with